Simultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 65, Issue 4, 2006, Pages 535-537

  Nielen, M M J ^a   Van Schaardenburg, D ^a,b   Reesink, H W ^c   Twisk, J W R ^b   Van De Stadt, R J ^a   Van Der Horst Bruinsma, I E ^b   De Koning, M H M T ^a   Habibuw, M R ^c   Dijkmans, B A C ^a,b  

^a JAN VAN BREEMEN INSTITUTE   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Sanquin Bloedbank Regio Noordwest Amsterdam   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; C REACTIVE PROTEIN; IMMUNOGLOBULIN M; PHOSPHOLIPASE A2;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; STATISTICAL ANALYSIS;

ACUTE-PHASE REACTION; AGE OF ONSET; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; PHOSPHOLIPASES A; RHEUMATOID FACTOR;

EID: 33645127251     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2005.040659     Document Type: Article

References (8)

1. Aho K, Heliovaara M, Maatela J, Tuomi T, Palosuo T. Rheumatoid factors antedating clinical rheumatoid arthritis. J Rheumatol 1991;18:1282-4.
2. Rantapää-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003;48:2741-9.
3. Nielen MMJ, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004;50:380-6.
4. Nielen MMJ, van Schaardenburg D, Reesink HW, Twisk JW, van de Stadt RJ, van der Horst-Bruinsma IE, et al. Increased levels of C-reactive protein in serum from blood donors before the onset of rheumatoid arthritis. Arthritis Rheum 2004;50:2423-7.
5. Wolbink GJ, Schalkwijk C, Baars JW, Wagstaff J, van den Bosch H, Hack CE. Therapy with interleukin-2 induces the systemic release of phospholipase-A2. Cancer Immunol Immunother 1995;41:287-92.
6. Twisk JWR. Applied longitudinal data-analysis for epidemiology: a practical guide. Cambridge, UK: Cambridge University Press, 2003.
7. Vossenaar ER, van Venrooij WJ. Anti-CCP antibodies, a high specific marker for (early) rheumatoid arthritis. Clin Applied immunol Rev 2004;4:239-62.
8. Cambridge G, Leandro MJ, Edwards JCW, Ehrenstein MR, Salden M, Bodman-Smith M, et al. Serological changes following B lymphocyte depletion therapy for rheumatoid arthritis. Arthritis Rheum 2003;48:2146-54.